Description
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the deterioration of both upper and lower motor neurons in the brain, brain stem, and spinal cord. Multiple missense mutations have been connected to ALS, including mutations in the

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the deterioration of both upper and lower motor neurons in the brain, brain stem, and spinal cord. Multiple missense mutations have been connected to ALS, including mutations in the Matr3 gene. Matrin-3 is an RNA and DNA-binding protein encoded by the Matr3 gene. Normally found in the nuclear matrix, Matrin-3 plays several roles vital to RNA metabolism, including splicing, mRNA transport, mRNA stability, and transcription. The most common Matr3 mutation identified in familial ALS (fALS) patients is the S85C mutation, but the mechanisms through which it contributes to ALS pathology remain unknown. This makes mouse models particularly useful in elucidating pathological mechanisms, having the potential to serve as preclinical models for therapeutic drugs. For this thesis project, an ALS mouse model for the Matr3 S85C mutation was created, specifically generating a CRISPR/Cas9 mediated knock-in mouse model containing the Matr3 S85C mutation expressed under the control of the endogenous promoter. The Matr3S85C/S85C mice displayed significant phenotypic differences, such as reduced size, impaired motor coordination, and shortening of lifespan. Moreover, the Matr3S85C/S85C mice exhibited ALS-like pathology in both the muscle and central nervous system (CNS). Muscle pathology included decreased muscle fiber size and Matrin-3 loss. CNS pathology included selective neurodegeneration, Matrin-3 loss, neuroinflammation, and reduction of N6-methyladenosine (m6A) RNA modifications. Bulk RNA sequencing (RNA-seq) revealed significant differential gene expression in the Matr3S85C/S85C mice compared to Matr3+/+ mice, with synaptic pathways being particularly affected. Overall, the Matr3 S85C mutation induced both phenotypic effects and ALS-like pathology in vivo.
Reuse Permissions
  • 1.23 MB application/pdf

    Download restricted until 2026-05-01.

    Details

    Title
    • Neurodegenerative Pathology in the Matr3 S85C Knock-In ALS Mouse Model
    Contributors
    Date Created
    2024
    Resource Type
  • Text
  • Collections this item is in
    Note
    • Partial requirement for: M.S., Arizona State University, 2024
    • Field of study: Molecular and Cellular Biology

    Machine-readable links